The effector functions of CD4 + cells in vivo are presumed to reflect a combination of lymphokine-mediated bystander reactions and direct cytotoxic T lymphocyte activity. To assess the relative importance of these two mechanisms, we studied the effects of transferring small doses of purified unprimed CD4 + cells to lightly irradiated (600 cGy) recipients expressing major histocompatibility complex class II (Ia) differences. Within the first week after transfer, the host marrow was rapidly repopulated with hemopoietic cells. Thereafter, however, the donor CD4 + cells caused massive destruction of hemopoietic cells, both in marrow and spleen. Marrow aplasia did not affect stromal cells and was prevented by coinjecting donor but not host bone marrow. The use of allotypic markers and fluorescence-activated cell sorter analysis indicated that the destructive effects of CD4 + cells were directed selectively to host Ia + hemopoietic cells, including stem cells; donor hemopoietic cells and Ia-host T cells were spared. No evidence could be found that the ongoing destruction of host cells impaired the capacity of donor stem cells to repopulate marrow, spleen, or thymus. Moreover, CD4 + cells failed to destroy host-type hemopoietic cells from h-deficient mice. Tissue destruction by CD4 § cells thus did not seem to reflect a bystander reaction. We conclude that, under defined conditions, CD4 + cells can manifest extremely potent h-restricted CTL activity in vivo, probably through recognition of covert Ia expression on stem cells and/or their immediate progeny.
C
TLs play a vital role in many forms of cellular immunity and are largely responsible for elimination of viruses and rejection of allografts (1) . Most of the effector cells for CTL responses are CD8 + cells. CD4 + cells make an important contribution to CTL responses, but CD4 + cells are thought to function largely by providing help (lymphokines) for CD8 + precursor cells rather than by acting as CTL effector cells. Nevertheless, there are a number of reports that, under defined conditions, CD4 + cells do exhibit CTL activity (2) (3) (4) (5) (6) (7) (8) (9) . The cytotoxic properties of CD4 + cells are most prominent with long-term T cell clones, but CTL activity is also seen for primary responses (2, 6) . Most cytotoxic CD4 § cells display a Thl phenotype (3, 8) . In mice, CTL activity by CD4 + cells generally involves cell contact leading to apoptosis (7) , but TNF-mediated lysis has also been reported (9) .
Whether CD4 + cells act as CTL under normal physiological conditions in vivo is unclear. In terms of allograft rejection (10) and induction of lethal GVHD (11) , CD4 + cells are known to exhibit potent effector function. The prevailing view is that the in vivo effector functions of CD4 § cells probably reflect a combination of lymphokine-mediated "bystander" reactions and direct CTL activity (10) . However, the relative importance of these two mechanisms is unknown.
In this paper we investigated whether CD4 § cells mediate bystander tissue destruction in vivo by transferring purified CD4 + cells to lightly irradiated MHC class II (Ia)-different hosts. The results show that, even in small doses, allogeneic CD4 + cells are capable of causing massive destruction of host hemopoietic cells, both in spleen and marrow. The surprising finding, however, is that destruction of hemopoietic cells by CD4 + cells seems to be directed solely to host cells and not to donor-derived cells. Moreover, marrow-derived cells from h-deficient (knockout) mice are completely resistant to destruction by aUogeneic CD4 § cells. Tissue destruction by CD4 + cells thus does not appear to reflect a bystander reaction but rather a highly potent form of direct Ia-restricted CTL activity.
Results
In previous studies from this laboratory (The Scripps Research Institute), we examined the capacity of CD4 + cells to cause lethal GVHD in irradiated hosts using the strain combination of B6 and bin12 (14) . These two strains are identical except for several point mutations in the ~ chain of the I-A molecule. When small doses of B6 CD4 + cells were transferred to lightly irradiated (600 cGy) (B6 x bm12)Fl hosts, the recipients died suddenly from GVHD at 3 wk after transfer, apparently from acute hemopoietic failure. Other workers (17) had reported similar findings for h-different mice injected with unseparated T cells. The surprising finding was that acute GVHD in lightly irradiated (B6 x bm12)Fl hosts failed to occur when B6 CD4 + cells were supplemented 1 Abbreviation used in this paper: BM, bone marrow. with donor BM cells or a mixture of donor and host BM cells (14) .
The initial aim of the experiments outlined below was to determine why the presence of donor BM cells prevents CD4 + cells from mediating lethal GVHD in lightly irradiated Ia-different hosts. Unless stated otherwise, doses of 2 x 106 highly purified LN CD4 § cells were transferred intravenously to adult (B6 x bm12)F1 hosts exposed to a low dose of 600 cGy 4-6 h before; BM cells (2 x 106) were T-depleted and were injected alone or as a mixture with T cells.
Acute Lethal GVHD Induced by CD4 + Cells in Lightly Irradiated Ia-different Hosts Reflects BM Aplasia. When a dose of 2 x 106 B6 CD4 + cells was transferred to 600 cGy (B6 x bml2)Ft hosts, the mice became acutely ill 16-18 d after transfer and died several days later. This was an invariable finding (seen in >10 experiments) and death rates were virtually 100%. When the mice were killed at days 16-18, the mice were obviously anemic and numbers of white blood cells and erythrocytes in peripheral blood were markedly reduced (data not shown). This pancytopenia was associated with striking atrophy of the host marrow, the numbers of nucleated cells in the long bones (tibiae) being reduced by 20-200-fold relative to mice treated with irradiation alone (Table 1) . Splenic atrophy was moderate on day 16 (Table 1) but was marked by days 18-21 (see below).
Supplementing the injected B6 CD4 § cells with host F1 (Table 1) or bm12 BM cells (see below) had no effect on BMApleen atrophy and failed to prevent death. However, adding donor BM cells, or a mixture of donor and host BM cells, caused minimal BM atrophy and resulted in prominent splenomegaly and virtually complete protection against death (Table 1) .
In hosts injected with B6 CD4 + cells in the absence of B6 stem cells, histological examination of the host long bones at days 16-18 revealed an almost complete absence of nucleated hemopoietic cells in the marrow cavities (Fig. 1, b and at) . It is significant, however, that the stromal cells in the marrow were well preserved. When B6 CD4 + cells were supplemented with B6 BM cells or a mixture of B6 and either F1 or bm12 BM cells, there was no evidence of marrow atrophy and the marrow was filled with dense accumulations of hemopoietic cells (Fig. 1, a and c) . In this situation, the histology of the marrow was indistinguishable from the marrow of control mice given 600 cGy alone (data not shown).
The dose of B6 CD4 § cells required to induce BM atrophy in irradiated (B6 x bm12)F1 hosts was surprisingly low, since as few as 7 x 104 cells were sufficient to cause complete atrophy (Fig. 2 a) . As a control for these studies with B6 CD4 § cells, we examined the dose of B6 CD8 § cells required to cause host marrow atrophy in 600 cGy (B6 x bml)F1 hosts (Fig. 2 b) . In this strong MHC class I-different combination, induction of marked marrow atrophy necessitated injecting in the order of 3 x 10 s B6 CD8 + cells, i.e., fourfold more cells than were needed for CD4 + cells in the B6 --~ bin12 combination.
As shown in Table 2 , Exp. 1, the capacity of CD4 + cells Table  3 and Fig. 3 . When (B6 x bm12)F1 mice were treated with 600 cGy alone, the cellularity of the marrow on day 2 was reduced by 10-20-fold relative to unirradiated mice (Table  3) cGy F1 mice were injected with B6 CD4 § cells, either alone or with F1 BM cells, the increase in marrow counts between days 2 and 7 was the same as in uninjected irradiated mice, indicating that CD4 + cells did not prevent initial repopulation of the host marrow. Between days 7 and 16, however, the cellularity of the marrow dropped precipitously. Adding large doses of F1 BM cells (2 x 107) failed to prevent this late onset of marrow atrophy (Table 3) . When the cellularity of the marrow was measured at 2-d intervals, the onset of marrow atrophy in F1 mice given B6 CD4 + cells (data not shown) or B6 CD4 + cells plus F1 BM cells (Fig. 3 a) first became evident 8-10 d after transfer. Thereafter marrow counts declined abruptly and reached very low levels by day 12. Similar kinetics applied to cell counts in spleen (Fig. 3 b) . Spleen weights were mildly increased relative to uninjected control mice 6-10 d after transfer and then decreased to below the control levels after day 14 (Fig. 3 c) . This applied to B6 CD4 + cells transferred in the absence of B6 BM cells. When B6 CD4 § cells were supplemented with syngeneic B6 BM cells, massive splenomegaly occurred: spleen weights were maximal ~2 wk after transfer and then gradually declined towards normal levels over the next 2-3 wk (Fig. 3 d and data not shown); marrow counts remained close to control levels throughout the period studied (data not shown).
Marrow Aplasia Includes Stem Cells. To examine whether the destruction of host marrow cells by CD4 + cells included stem cells, the few cells remaining in the host marrow at 14 d after transfer were assayed for CFUs using standard procedures (see Materials and Methods); the cells (pooled from 9 mice) were treated with anti-Thy-1 mAb plus C before transfer to remove mature T cells. As shown in To distinguish between these two possibilities, 600 cGy (B6 x bm12)F1 mice (Ly 5. (Fig. 4) , Thy 1-host Ly 5.2 + cells were virtually absent in in the mice given a mixture of B6 CD4 + calls and B6-Ly 5.1 BM cells. Similar findings applied to the Thy 1-T cells in spleen (Fig.  4) . As a control in this experiment, some of the mice were injected with B6-Ly 5.1 BM cells plus bin12 CD4 + cells and bin12 BM ceils (both Ly 5.2). The expectation here was that the bin12 CD4 + cells would kill the allogeneic B6-Ly 5.1 BM cells (and also host F1 BM cells) but spare the syngeneic bm12 BM cells, thus causing complete repopulation with Ly 5.2 + cells, i.e., with bm12-derived cells. This was indeed the case (Fig. 4) .
The data in Fig. 4 
Resistance of Ia-BM Cells to Destruction by CD4 + Cells.
The above data on phenotyping of marrow cells and thymocytes indicate that the destructive function of CD4 § cells is strongly Ia restricted and is directed, at least in part, to stem cells. The key problem with this scenario is that despite ex- In each experiment, T cells and BM cells were injected in a dose of 2 x 106 cells/mouse. The mice were analyzed at 14--16 d after transfer. The data represent the mean of three mice per group.
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Destruction of Stem Cells by CD4 + Ceils haustive attempts we were unable to demonstrate Ia expression on stem cells. Thus, even after incubation with lymphokines in vitro, treating marrow cells with anti-Ia mAb plus C and/or removing Ia + cells by panning failed to cause any significant reduction in CFUs or remove pluripotential stem cells (data not shown). Since the above methods might not be sufficiently sensitive to detect limited (but physiologically significant) Ia expression on stem cells, we examined whether CD4 + cells could destroy BM cells taken from Ia "knockout" (Ia ~ mice; the Ia ~ line used was backcrossed to the B6 background (12) . As shown in Table 5 , BM cells from this line were completely resistant to the cytotoxic effects of bin12 CD4 + cells. Thus, whereas bm12 § CD4 § cells caused marked marrow and spleen atrophy when transferred to 600 cGy (B6 x bm12)F1 mice with B6 BM cells, transferring bm12 CD4 + cells with B6 Ia ~ BM cells caused no sign of marrow atrophy and led to splenomegaly ( Table 5 , Exp. 1 and 2) . Control experiments indicated that the B6 Ia ~ BM ceUs retained sensitivity to marrow aplasia directed to class I antigens. Thus, as with B6 BM cells, transferring B6 Ia ~ BM cells to 600 cGy (B6 x bml)F1 hosts in the presence of bin1 CD8 + cells led to marked marrow atrophy (Table 5 
Discussion
This article documents that small doses of normal CD4 + cells transferred to lightly irradiated Ia-different hosts caused profound atrophy of host hemopoietic cells 2-3 wk after transfer. By all parameters studied, the destruction of hemopoietic cells by CD4 + cells was limited to Ia + host ceils. Evidence for bystander damage of donor BM-derived cells or Ia-host cells was conspicuously absent. The key question is whether the injected CD4 + ceils destroyed hemopoietic cells via direct Ia-restricted CTL activity.
The notion that the injected CD4 + cells killed host hemopoietic ceils via direct CTL activity strains credulity when it is borne in mind that complete marrow atrophy in the B6/bm12 combination was induced by as few as 7 x 104 CD4 + cells. Thus, taking into consideration the extensive size of the host marrow, it is extremely difficult to envisage how the antigen-reactive progeny of such a conspicuously small dose of CD4 + cells caused virtually complete destruction of host marrow cells in a brief period, i.e., during the second week after transfer. Surely one has to argue in terms of cell destruction by humoral factors?
In this respect, perhaps the simplest possibility is that the host cells were destroyed through the production of anti-Ia antibody, i.e., by donor-derived B cells. There are three crucial problems with this idea. First, given that the injected CD4 + cells were effective in very small doses and were highly purified, the number of contaminating B cells in the injected CD4 § cells must have been extremely low. Moreover, the purification method used to prepare the CD4 + cells included treatment with anti-Ia mAb plus C in doses sufficient to kill >95% of spleen B cells. Second, to our knowledge the antigenic difference between I-A and I-A bin12 is serologically undetectable. Third, and most importantly, we have been unable to detect antibody activity in the serum of irradiated (B6 x bm12)F1 hosts injected with B6 CD4 § cells (data not shown). For these reasons, it is very difficult to sustain the argument that host hemopoietic cells were destroyed via anti-Ia antibody. It is also worth noting that treating normal or lymphokine-induced BM cells with high concentrations of anti-Ia mAb plus C failed to impair stem cell activity. Yet stem cells appeared to be one of the main targets of attack by CD4 + cells (see below).
Another possibility is that hemopoietic cells were destroyed via local production of toxic cytokines such as TNF. This notion deserves serious consideration because anti-TNF-c~ mAb is reported to be highly effective in preventing some of the in vivo effector functions of CD4 + cells, e.g., gut damage associated with GVHD (19) . The chief problem with the idea that tissue destruction reflected local production of toxic cytokines is that bystander damage by CD4 + cells appeared to be remarkably limited. Thus the disapperance of host hemopoietic cells in the marrow did not seem to injure host stromal cells or cause significant impairment of donor BM-derived repopulation of marrow and thymus. These findings, plus the failure of CD4 + cells to destroy residual radioresistant host T cells or host-type BM cells from Iadeficient mice, strongly suggest that the destruction of host cells was directed exclusively to host Ia + cells.
For the reasons cited above, it is very difficult to explain the destruction of hemopoietic cells by CD4 + cells in terms of humoral factors. By exclusion, one is thus forced to consider the possibility that the injected CD4 + cells killed host hemopoietic cells via direct Ia-restricted CTL activity. All of the available data are consistent with this possibility. The following model can be considered. During the first week after transfer, the intravenously injected CD4 + cells homed to the spleen and became sensitized to host Ia antigens expressed on dendritic cells. The host-reactive CD4 + cells then underwent considerable clonal expansion, differentiated into effector cells, and percolated throughout the body, including the BM (where >50% of the cells from aplastic marrow were donor CD4 § cells). Through direct CTL activity, the effector cells then destroyed Ia + cells, leaving Ia-host cells and Ia § donor cells untouched.
At least two objections can be raised against this scenario.
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Sprent et al. First, one has to explain how typical BM cells, most of which are largely Ia-, could be destroyed en masse by CD4 + cells. The explanation we favor here is that the CTL activity of CD4 + cells is directed predominantly to various types of stem cells and/or their immediate progeny. In the absence of stem cells, the short-lived, terminally differentiated descendants of these cells rapidly disappear and hemopoietic failure results. In support of this idea, we observed a marked paucity of stem cells in the atrophic marrow of mice given CD4 § cells. It is disturbing, however, that we failed to find evidence of Ia expression on stem cells by antibody plus C treatment or by panning. Moreover, studies in both humans (20) and mice (Spangrude, J., and I. Weissman, personal cornmunication) have found that purified pluripotential stem cells (nonlymphokine induced) are Ia-by FACS | analysis. Despite these findings, it is striking that the destruction of B6 BM cells by bm12 CD4 + cells did not apply to B6 BM cells from Ia-deficient mice. This finding strongly suggests that Ia expression on stem cells is physiologically significant and sufficient to act as a target for CD4 + cells. Since the stem cell targets for CD4 + cells in irradiated hosts are probably cycling and exposed to various cytokines, it would seem likely that Ia expression on stem cells has to be induced. In favor of this possibility, it has been found that Ia expression on human stem cells can be upregulated by lymphokines (20) . We presume the same applies to mouse stem cells but this remains to be proved. The second problem with the notion that CD4 § cells destroy hemopoietic cells via direct CTL activity is that we have had little success in demonstrating more than minimal CTL activity by CD4+cells in vitro. In several experiments we observed significant class II-restricted lysis of tumor cells and LPS blasts by in vivo-sensitized CD4 + cells in the B6/bm12 combination (our unpublished data). However, the level of killing was quite low-far lower than for anti-class I killing by CD8 + cells-unless the effector cells were restimulated with antigen in vitro. Yet Ia-restricted tissue destruction by CD4 + cells in vivo was as potent, or more potent, than the destruction mediated by CD8 + cells responding to a class I difference. In view of this paradox, the existing techniques for demonstrating CTL activity by CD4 § cells in vitro may be a poor model for the in vivo functions of these cells (6) . Whatever the explanation for the mechanism of tissue destruction, the finding that very small doses of CD4 § cells were capable of mediating massive Ia-restricted destruction ofhemopoietic cells in irradiated hosts with no evidence of an overt bystander reaction indicates that the CTL activity of CD4 § cells in vivo is extremely potent. Direct evidence on whether the CTL activity of CD4 + cells in vivo reflects direct lysis or the local release of humoral factors will have to await further investigation. As a footnote it may be mentioned that destruction of stem cells by CD4 + CTL could explain the finding that BM engraftment across Ia barriers is enhanced when the recipients are depleted of CD4 + cells (21) .
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